Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 12/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4466274 | 1.00 | KIF11 (0.45) | KIF11NPC1RAB9APKMDNMT1 | |
| SCHEMBL4468277 | 0.89 | ALDH1A1 (0.49) | KIF11NPC1RAB9APKMDNMT1 | |
| SCHEMBL4458679 | 0.89 | ALDH1A1 (0.49) | KIF11NPC1RAB9APKMDNMT1 | |
| SCHEMBL4462184 | 0.78 | ALDH1A1 (0.47) | KIF11NPC1RAB9APKMALDH1A1 | |
| SCHEMBL4462177 | 0.78 | ALDH1A1 (0.47) | KIF11NPC1RAB9APKMALDH1A1 | |
| SCHEMBL4465417 | 0.78 | ALDH1A1 (0.47) | NPC1RAB9APKMALDH1A1MAPK1 | |
| SCHEMBL4465412 | 0.78 | ALDH1A1 (0.47) | NPC1RAB9APKMALDH1A1MAPK1 | |
| SCHEMBL4455228 | 0.77 | KMT2A (0.48) | KIF11NPC1RAB9ADNMT1ALDH1A1 | |
| SCHEMBL4455232 | 0.77 | KMT2A (0.48) | KIF11NPC1RAB9ADNMT1ALDH1A1 | |
| SCHEMBL4452867 | 0.75 | RAB9A (0.39) | NPC1RAB9APKMALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009151744-A1 | S-NITROSOMERCAPTO COMPOUNDS AND RELATED DERIVATIVES | GALLEON PHARMACEUTICALS, INC. (US) | 2009-12-17 | — | — | WO | disclosed |